The Female Hormone Stack: By Life Stage, Not One Formula
Cycle symptoms, PCOS and perimenopause are three different problems, and a single hormone balance formula cannot address them because they are not one thing.
The Short Answer
Hormone balance is an unmeasurable target, which is why products sold against it cannot be evaluated. The measurable questions are specific: cyclical premenstrual symptoms, features of PCOS with insulin resistance and androgen excess, or perimenopausal vasomotor and sleep disruption. Each has its own evidence base and its own reasonable stack, and a single formula marketed for all three is addressing none of them.
The Foundation, Common to All Stages
Iron, where ferritin is low. The most commonly missed contributor to fatigue in menstruating women, and heavy bleeding makes it more likely. Alternate-day dosing absorbs better than daily, and low stores need a cause identified.
Vitamin D, where status is low.
Adequate protein, which matters for lean mass and bone at every stage and increasingly with age.
Resistance training and impact loading, particularly important given the bone trajectory across the menopausal transition.
Adequate energy availability. Sustained deficit combined with high training volume suppresses the axis, disrupts cycles and reduces bone density, and it is the single most consequential avoidable pattern in younger women.
Sleep regularity, which affects the axis and is disrupted at several stages.
Thyroid function checked, since thyroid dysfunction is more common in women and its symptoms overlap heavily with hormonal ones.
These are not stage-specific and they carry more weight than anything below.
Cyclical and Premenstrual Symptoms
Vitex agnus-castus. Several trials support benefit for cyclical breast tenderness and premenstrual symptoms, plausibly through dopaminergic effects on prolactin. It has theoretical interactions with hormonal contraception and dopaminergic medication, and it is the best-evidenced botanical in this area.
Magnesium, 200 to 400 mg elemental. Modest evidence for premenstrual symptoms, low cost, low risk.
Vitamin B6. Some evidence for premenstrual symptoms. Doses should stay moderate, since prolonged high-dose B6 causes peripheral neuropathy, which is a genuine and sometimes irreversible harm.
Calcium. Some trial evidence for premenstrual symptoms, and dietary sources are preferred given the cardiovascular questions around supplements.
Omega-3. Some evidence for dysmenorrhoea.
What matters beyond supplements: exercise has reasonable evidence for premenstrual symptoms, and hormonal contraception is an effective option for cycle-related symptoms that belongs in a clinical conversation.
When to escalate: symptoms severe enough to disrupt function may be premenstrual dysphoric disorder, which has specific effective management and is under-recognised. Heavy bleeding warrants assessment for iron shortfall and for a cause.
PCOS
| Component | Evidence |
|---|---|
| Myo-inositol, often with D-chiro-inositol | Reasonable trial support for insulin sensitivity, ovulatory function and androgen markers |
| Weight management where relevant | Improves insulin sensitivity, cycles and androgen levels; the largest lever |
| Exercise, particularly resistance training | Improves insulin sensitivity independent of weight change |
| Vitamin D, where low | Commonly low in PCOS; correction reasonable |
| Omega-3 | Modest effects on lipids and inflammatory markers |
| Berberine | Glycaemic effects; drug-like interactions require a medication review |
| N-acetylcysteine | Some trial data on ovulatory outcomes; earlier |
| Spearmint tea | Small trials on androgen markers; minor |
Inositol is the best-supported supplement in this article, and the framing that makes PCOS tractable is that it is substantially a metabolic condition. Insulin resistance drives ovarian androgen production, so improving insulin sensitivity addresses the mechanism rather than the symptom.
PCOS also warrants clinical management rather than self-directed supplementation alone, since metformin, combined hormonal contraception, anti-androgens and ovulation induction all have roles depending on the goal, and the cardiometabolic risk that accompanies it needs monitoring.
Perimenopause and After
This is the stage where supplements are most heavily marketed and least effective relative to the available alternative.
What has some evidence: black cohosh for vasomotor symptoms, with mixed trial results and rare hepatotoxicity reports that make liver monitoring reasonable. Soy isoflavones, with modest and inconsistent effects, and equol-producing capacity varying between individuals. Vitamin D and calcium for bone, preferring dietary calcium. Magnesium for sleep.
What has little: most proprietary menopause formulas, wild yam creams, which do not convert to progesterone in humans, and compounded bioidentical hormone preparations sold as safer alternatives, which are not standardised and lack the safety data of licensed preparations.
What has substantial evidence: hormone therapy for bothersome vasomotor symptoms. Current guideline positions support it as effective, with risk depending on age, time since menopause, formulation and route. The historical over-reaction to early trial reporting left many women without an option that was appropriate for them, and current guidance is more nuanced than that legacy suggests.
That comparison is the honest centre of this section. A woman with disruptive vasomotor symptoms is better served by a clinical conversation about hormone therapy than by a botanical with mixed evidence, and non-hormonal prescription options exist for those who cannot or prefer not to use it.
Post-menopause, what matters shifts: apolipoprotein B and blood pressure as cardiovascular risk rises, bone density assessment, protein and resistance training, and vitamin D. These are not hormone supplements and they are what the evidence supports.
What to Avoid at Every Stage
Products marketed for hormone balance without specifying which hormone or how the effect would be measured. An unmeasurable claim.
Salivary and dried urine hormone panels, which are not validated for reproductive hormone assessment and generate protocols from unvalidated interpretation.
Wild yam and diosgenin creams sold as natural progesterone. Diosgenin does not convert to progesterone in the human body.
Compounded hormone preparations presented as safer than licensed ones, which are not standardised in dose and lack comparable safety data.
High-dose B6 over prolonged periods, given the peripheral neuropathy risk.
Herbal products with oestrogenic activity in anyone with a hormone-sensitive cancer history, without clinical input.
DHEA, a precursor hormone with unpredictable conversion and androgenic effects in women including acne, hirsutism and hair loss.
Anything replacing a clinical conversation where symptoms are affecting function, since effective options exist and delay costs quality of life.
The AEONNN Perspective
AEONNN does not recognise hormone balance as a target, because it cannot be measured and therefore cannot be evaluated. What the platform works with instead are three distinct questions with three distinct evidence bases: cyclical premenstrual symptoms, PCOS with insulin resistance and androgen excess, and the perimenopausal transition.
Inositol in PCOS is the best-supported supplement here, and it works because PCOS is substantially metabolic, which puts Pillar 4 upstream of a Pillar 2 presentation. Vitex has the strongest botanical evidence for premenstrual symptoms. Everything else in the foundation, iron where ferritin is low, adequate protein, resistance training, energy availability and sleep, carries more weight than the stage-specific additions.
The platform is explicit where a clinical option outperforms a supplement, and perimenopause is the clearest case: hormone therapy has substantial evidence for bothersome vasomotor symptoms under current guidance, and a botanical with mixed evidence is not an equivalent. The Safety layer excludes wild yam creams, which do not convert to progesterone in humans, unstandardised compounded preparations, prolonged high-dose B6 given neuropathy risk, and DHEA for its androgenic effects in women.
Pillar Matrix mapping
Database Matrix layers
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
- Safety Layer (DrugBank, FAERS)
- Population Layer (UK Biobank, NHANES)
Frequently Asked
Is there a hormone balancing supplement?
Hormone balance is not a measurable target, so products sold against it cannot be evaluated. The measurable questions are premenstrual symptoms, PCOS and the perimenopausal transition, each with its own evidence.
What helps premenstrual symptoms?
Vitex agnus-castus has the strongest botanical evidence, with magnesium and vitamin B6 at moderate doses adding modestly. Exercise has reasonable evidence, and hormonal contraception is an effective clinical option.
What is the best supplement for PCOS?
Myo-inositol, often with D-chiro-inositol, has reasonable trial support for insulin sensitivity, ovulatory function and androgen markers. Weight management and exercise are the larger levers.
Do natural progesterone creams work?
Wild yam and diosgenin creams do not. Diosgenin does not convert to progesterone in the human body.
What works for hot flushes?
Hormone therapy has substantial evidence and current guideline positions support it as effective for bothersome vasomotor symptoms. Black cohosh has mixed evidence with rare hepatotoxicity reports.
Are compounded bioidentical hormones safer?
They are not standardised in dose and lack the safety data of licensed preparations. Being presented as safer is a marketing claim rather than an evidenced one.
What matters after menopause?
Apolipoprotein B and blood pressure as cardiovascular risk rises, bone density assessment, protein and resistance training, and vitamin D. These are not hormone supplements.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.